Lavivo is a biotechnology company developing preventions
and treatments for people who suffer from gastrointestinal (GI) imbalance and infections impacting the bodily function. The company has developed the QUALVIVO bacterial system as platform for live bacterial therapy, delivering live beneficial bacteria, harnessing the power of the human microbiome.
Through close cooperation with scientists and experts within the focused technologies Lavivo can offer products and concepts based on the latest developments in research.
Learn more about the Qualvivo system concept.
Contact Mr. Mats Wallstrom.